Latest news
Alto Ingredients And 2 Other Promising Penny Stocks - simplywall.stsimplywall.st · Tue, 04 Aug 2026 14:08:27 GMTRocket Pharmaceuticals Reports Positive Safety Update for RP-A501 Under Modified Phase 2 Protocol in Danon Disease - BioPharm InternationalBioPharm International · Mon, 03 Aug 2026 17:07:07 GMTRocket Pharmaceuticals (RCKT) Reports Positive Safety Signals in Phase 2 Trial for Danon Disease - GuruFocusGuruFocus · Mon, 03 Aug 2026 13:01:56 GMTRocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease - Business WireBusiness Wire · Mon, 03 Aug 2026 11:00:00 GMTVanguard Portfolio Management (RCKT) reports 5.35% Rocket Pharmaceuticals ownership - Stock TitanStock Titan · Fri, 31 Jul 2026 15:41:22 GMT